Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Melamed

Showing results (131-140 of 202) with videos related to

Pageof 21
Sort By:
American Journal of Clinical and Experimental Urology|January 22, 2015
De novo large cell neuroendocrine carcinoma of the prostate, case report and literature reviewGabriel Acosta-Gonzalez, Jia Qin, Rosemary Wieczorek, et al.
American Journal of Clinical and Experimental Urology|April 13, 2016
Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature reviewSergei Guma, Remegio Maglantay, Ryan Lau, et al.
Radiology|May 3, 2012
Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancerAndrew B Rosenkrantz, Eric E Sigmund, Glyn Johnson, et al.
European Radiology|August 21, 2012
Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinomaAndrew B Rosenkrantz, Aarti Sekhar, Elizabeth M Genega, et al.
Urologic Oncology|August 12, 2024
Intraoperative margin assessment with near real time pathology during partial gland ablation of prostate cancer: A feasibility studyMiles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2020
A pilot investigation of couple-level phthalates exposure and in vitro fertilization (IVF) outcomesThoin F Begum, Victor Y Fujimoto, Roy Gerona, et al.
JCI Insight|November 24, 2025
Targeting p300 and CBP abolishes HOXB13-loss-induced lipogenesis and tumor metastasisXiaodong Lu, Liu Peng, Qi Chu, et al.
Urologic Oncology|September 5, 2015
A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomyClement Orczyk, Andrew B Rosenkrantz, Fang-Ming Deng, et al.
Plos One|January 27, 2011
TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growthJoseph H Jeong, Ayesha Bhatia, Zsolt Toth, et al.
Endocrine-Related Cancer|November 19, 2013
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growthGarrett Daniels, Yirong Li, Lan Lin Gellert, et al.
Pageof 21

Showing results (131-140 of 202) with videos related to

Sort By:
Pageof 21
American Journal of Clinical and Experimental Urology|January 22, 2015
De novo large cell neuroendocrine carcinoma of the prostate, case report and literature reviewGabriel Acosta-Gonzalez, Jia Qin, Rosemary Wieczorek, et al.
American Journal of Clinical and Experimental Urology|April 13, 2016
Papillary urothelial carcinoma with squamous differentiation in association with human papilloma virus: case report and literature reviewSergei Guma, Remegio Maglantay, Ryan Lau, et al.
Radiology|May 3, 2012
Prostate cancer: feasibility and preliminary experience of a diffusional kurtosis model for detection and assessment of aggressiveness of peripheral zone cancerAndrew B Rosenkrantz, Eric E Sigmund, Glyn Johnson, et al.
European Radiology|August 21, 2012
Prognostic implications of the magnetic resonance imaging appearance in papillary renal cell carcinomaAndrew B Rosenkrantz, Aarti Sekhar, Elizabeth M Genega, et al.
Urologic Oncology|August 12, 2024
Intraoperative margin assessment with near real time pathology during partial gland ablation of prostate cancer: A feasibility studyMiles P Mannas, Fang-Ming Deng, Adrian Ion-Margineanu, et al.
Reproductive Toxicology (Elmsford, N.Y.)|December 3, 2020
A pilot investigation of couple-level phthalates exposure and in vitro fertilization (IVF) outcomesThoin F Begum, Victor Y Fujimoto, Roy Gerona, et al.
JCI Insight|November 24, 2025
Targeting p300 and CBP abolishes HOXB13-loss-induced lipogenesis and tumor metastasisXiaodong Lu, Liu Peng, Qi Chu, et al.
Urologic Oncology|September 5, 2015
A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomyClement Orczyk, Andrew B Rosenkrantz, Fang-Ming Deng, et al.
Plos One|January 27, 2011
TPL2/COT/MAP3K8 (TPL2) activation promotes androgen depletion-independent (ADI) prostate cancer growthJoseph H Jeong, Ayesha Bhatia, Zsolt Toth, et al.
Endocrine-Related Cancer|November 19, 2013
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growthGarrett Daniels, Yirong Li, Lan Lin Gellert, et al.
Pageof 21